Although the role of HMGB1 in the pathogenesis of interstitial lung diseases has not been elucidated, inhibition of necroptosis might also be beneficial for interstitial lung diseases complicated with inflammatory myopathies. Here, HMGB1 is linked to interstitial lung disease.